ESSA Pharma Inc (EPIX)
US Market

ESSA Pharma (EPIX) Financial Statements


ESSA Pharma Financial Overview

ESSA Pharma's market cap is currently ―. The company's EPS TTM is $-0.628; its P/E ratio is -8.34; ESSA Pharma is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -8.99M$ -5.96M$ -5.48M$ -7.30M$ -7.06M
EBITDA$ -8.97M$ -5.94M$ -5.64M--
Net Income Common Stockholders$ -8.99M$ -5.96M$ -5.48M$ -7.30M$ -7.06M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 135.89M$ 142.12M$ 148.08M$ 152.47M$ 157.04M
Total Assets$ 137.90M$ 144.49M$ 149.12M$ 153.65M$ 158.50M
Total Debt$ 353.66K$ 374.83K$ 80.33K$ 111.27K$ 145.27K
Net Debt$ -135.54M$ -141.74M$ -148.00M$ -152.36M$ -156.90M
Total Liabilities$ 4.43M$ 3.81M$ 3.50M$ 3.41M$ 2.17M
Stockholders Equity$ 133.47M$ 140.68M$ 145.63M$ 150.24M$ 156.34M
Cash Flow-
Free Cash Flow$ -6.82M$ -6.79M$ -4.49M--
Operating Cash Flow$ -6.82M$ -6.79M$ -4.49M--
Investing Cash Flow$ 62.51M$ 8.23M$ -264.65K--
Financing Cash Flow$ 643.60K$ 196.66K$ -13.65K--
Currency in USD

ESSA Pharma Earnings and Revenue History

ESSA Pharma Debt to Assets

ESSA Pharma Cash Flow

ESSA Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis